On the contrary, systemic FasL levels are lower in COVID‐19 patients (COVID‐19: 0.20 ng/mL vs. HD: 0.24 ng/mL, p < 0.05) (Figure 3E). The gene discussed is FASLG; the disease is COVID-19.